JIR
STAA icon

James Investment Research’s STAAR Surgical STAA Stock Holding History

James Investment Research’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-31,600
Closed -$1.01M – 899
2018
Q4 		$1.01M Buy
+31,600
New +$1.23M 0.06% 360

Other funds holding STAA

BC
Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

James Investment Research's STAA Position: Q1 2019 in Review

James Investment Research sold out of STAAR Surgical (STAA) in Q1 2019, closing a stake of 31,600 shares — an estimated $1.01M sold.

James Investment Research first reported a position in STAA in Q4 2018 and held it in 1 quarter. The position peaked at $1.01M in Q4 2018. 185 funds tracked by Wall St. Rank hold STAA as of Q1 2019.

  • James Investment Research reported no remaining STAAR Surgical position as of Q1 2019 after selling out during the quarter.
  • James Investment Research sold 31,600 STAAR Surgical shares in Q1 2019, an estimated $1.01M.
  • James Investment Research first reported a position in STAAR Surgical in Q4 2018 and held it in 1 quarter.
  • James Investment Research's STAAR Surgical position peaked at $1.01M in Q4 2018.
  • 185 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2019.

Based on James Investment Research's 13F filing for Q1 2019, filed 26 Apr 2019.